![Monika Tornsen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Monika Tornsen
Directeur/Membre du Conseil chez IMMUNIC, INC.
Profil
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Postes actifs de Monika Tornsen
Sociétés | Poste | Début |
---|---|---|
IMMUNIC, INC. | Directeur/Membre du Conseil | 05/07/2022 |
CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
Anciens postes connus de Monika Tornsen
Sociétés | Poste | Fin |
---|---|---|
PASSAGE BIO, INC. | Corporate Officer/Principal | 01/12/2022 |
SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2019 |
Formation de Monika Tornsen
University of Lund | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
PASSAGE BIO, INC. | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
IMMUNIC, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
Entreprise privées | 1 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |